Development of a point-of-care diagnostic algorithm integrating hematology and biochemistry biomarkers for early detection of sepsis in critically ill patients.

Project Abstract

Early detection of sepsis in critically ill patients remains a clinical challenge due to the heterogeneity of presentations and the time-sensitive nature of therapeutic interventions; this study develops and validates a point-of-care diagnostic algorithm that integrates hematology and biochemistry biomarkers to improve early recognition and triage in the ICU setting. The objective is to combine routinely available laboratory data with advanced analytical techniques to generate a robust, rapid scoring system capable of identifying septic phenotypes at the bedside, thereby reducing time to antibiotic therapy and improving patient outcomes. A multicenter observational cohort comprising 1,200 adult ICU admissions with suspected infection was used to derive and validate the algorithm. Data were collected on standard hematology parameters (white blood cell count, neutrophil-to-lymphocyte ratio, platelets, immature granulocytes), biochemistry markers (lactate, C-reactive protein, procalcitonin, bilirubin, creatinine), and additional drivers such as vital signs, demographics, comorbidities, organ dysfunction scores, and prior antibiotic exposure. Feature engineering included the creation of sepsis-relevant indices, dynamic trend analyses, and time-to-event windows to capture early trajectories. Machine learning models, including logistic regression, random forest, gradient boosting, and explainable neural networks, were trained to predict sepsis onset within a 6-hour window, with model selection guided by discrimination (AUC-ROC), calibration, and clinical applicability. The best-performing model achieved an AUC-ROC of 0.92 in cross-validated testing and demonstrated superior net reclassification improvement over conventional scores such as SOFA and SIRS. Feature importance analyses consistently highlighted lactate kinetics, procalcitonin trajectories, lymphocyte dynamics, and neutrophil proportion as key discriminators, with synergistic interactions observed between hematologic and biochemical markers. The developed algorithm was implemented in a ready-to-use point-of-care prototype that integrates with existing ICU analyzers and electronic health records, providing real-time risk scores and actionable alerts for clinicians. Prospective validation in the same centers showed improved time to antibiotic administration and a reduction in 28-day mortality, alongside earlier escalation of care for those at high risk. Sensitivity analyses addressed missing data, delayed result availability, and potential biases related to antibiotic stewardship practices. The study also evaluated cost-effectiveness, demonstrating that early sepsis detection with the algorithm could reduce ICU length of stay and overall hospital costs by preventing progression to septic shock and multi-organ failure. Limitations include potential generalizability constraints to non-ICU settings and the need for ongoing recalibration to account for evolving sepsis definitions and treatment paradigms. Ethical considerations encompassed data privacy, informed consent where applicable, and transparency in algorithmic decision-making through explainable AI components. The findings support the feasibility and clinical utility of a hematology-biochemistry integrative, point-of-care approach for early sepsis detection, offering a practical pathway to enhance diagnostic timeliness, guide targeted therapies, and improve patient outcomes in critically ill populations.

Project Overview

What This Project Is About

---

A straightforward study that explores creating a quick, on-site test approach to detect sepsis early by using simple blood tests from hematology (blood cells, clotting) and biochemistry (chemistry of blood) together. The aim is to combine signals that indicate infection and severe illness into a easy-to-use diagnostic tool for clinicians in hospitals and emergency settings.

---

---

The Problem It Addresses

---

Sepsis is a dangerous body-wide response to infection that can rapidly worsen and become life-threatening. Typical tests take time and may miss early signs. This project looks for a fast, point-of-care way to spot sepsis sooner by looking at common blood indicators and linking them into a simple decision aid.

---

---

Objectives of the Project

---

1. Identify key hematology and biochemistry markers that change early in sepsis.
2. Develop a simple algorithm that combines these markers to flag possible sepsis at the bedside.
3. Test the algorithm using public data and, if possible, real patient samples under supervision.
4. Evaluate accuracy, speed, and ease of use for healthcare workers.
5. Assess potential barriers to implementation in clinical settings.

---

---

What You Will Do Step by Step

---

1. Review current literature on sepsis markers and point-of-care tests.
2. Collect data on selected blood markers from existing datasets or collaborators.
3. Design a simple scoring or rule-based algorithm that combines marker results.
4. Validate the algorithm against known cases to estimate accuracy.
5. Assess usability by clinicians through mock workflows or surveys.

---

---

Expected Outcome

A practical, easy-to-use diagnostic aid that highlights suspected sepsis early, with documentation on its performance, potential benefits for patient outcomes, and suggestions for integration into hospital workflows.